Ronald Levy
Ronald Levy · Science & Medicine
Oncologist whose work on lymphoma led to rituximab, a pioneering cancer antibody drug.
1941, United States
United States
Ronald Levy is recognized among Jewish contributors to Science & Medicine — Oncologist whose work on lymphoma led to rituximab, a pioneering cancer antibody drug.
Levy, a Stanford oncologist, pioneered the use of monoclonal antibodies against cancer; his work on B-cell lymphoma led directly to rituximab, the first antibody drug approved for cancer and a treatment that has saved countless lives. He received the Warren Alpert and King Faisal prizes. He was born to a Jewish family.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biology
Oncologist whose work on lymphoma led to rituximab, a pioneering cancer antibody drug.
Source: Jinfo.org — Jews in Biology
Similar Contributors
John Mendelsohn
Viktor Hamburger
Lawrence Einhorn
Ján Vilček
